Avoiding Delays in Reporting Time-to-Event Randomized Trials: Highly relevant issue in this era of improving oncological outcomes; expert statistical opinion by SWOG Cancer Research Network Dr. Othus, NCI CTEP Clinical Research Dr. Freidlin and Dr. Korn. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

#InternationalClinicalTrialsDay Many thanks to all the patients who participate in #clinicaltrials and all those who develop, implement & administer clinical trials to improve health outcomes for everyone. OncoAlert SWOG Cancer Research Network The Hope Foundation for Cancer Research

Be a partner in progress against cancer! Learn about studies, consider clinical trials, and discover ways to participate in #CancerResearch : go.nih.gov/V0fkZiJ #ClinicalTrialsDay #NationalCancerResearchMonth

Our C Blanke, SWOG Chair blog:
May 20th is Intl #ClinicalTrialsDay , the ideal opportunity to say THANK YOU to 1,000s of oncology research professionals who make our trials work at clinical sites & behind the scenes, professionals who include @SWOG's amazing staff!
swog.org/news-events/ne…

We're requesting LOIs by June 1 for our #NCORP Pilot Grant Program - $50K awards to foster improved representation of under-resourced populations in cancer clinical trial accrual #SWOGonc w/SWOG Cancer Research Network

thehopefoundation.org/funding-opport…

MyeloMATCH MSRP: A Screening Study to Assign People with Myeloid Cancer to a Treatment Study - Activated 5/16/24 - #PrecisionMedicine #AMLsm #MDSsm #AllianceSpring2024 cancer.gov/research/parti…

This is going to be fun 😁 later this afternoon! One of the closing sessions Great Debates & Updates with 2 of my fave pple debating the role of #HAI in refractory MCRC Michael Lidsky, MD, FACS Duke Cancer vs Dr. Philip Philip Henry Ford Health #cancer #cancer research SWOG Cancer Research Network ECOG-ACRIN Cancer Research Group Yelena Y. Janjigian MD

The Lung-MAP trial is built on a unique public-private partnership including National Cancer Institute Foundation for the National Institutes of Health Friends of Cancer Research SWOG Cancer Research Network
#NCTNPartnership benefits:
- Shared costs & risks of testing therapies
- Drug combination collaborations between companies
- Large network shortens timeframes

Our C Blanke, SWOG Chair blog:
myeloMATCH: The Next Revolution in the #NCTN
I'm thrilled to be able to report that #myeloMATCH , National Cancer Institute's #precisionmedicine umbrella trial in acute myeloid #leukemia (AML) and #myelodysplastic syndrome (MDS), is approaching launch!
swog.org/news-events/ne…

🌟Excited to announce the launch of PARAMUNE trial! Grateful to my supporters SWOG Cancer Research Network NCI CTEP Clinical Research. Together, we're pioneering frontiers in immunotherapy, offering hope to those in need. Let's make a difference! 💫UPMC Hillman Cancer Center philip a philip Dr. Cathy Eng Dan Duda Rajiv Agarwal MD

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

Newly Activated #NCTN #EsophagealCancer #GastroesophagealCancer Trial: (S2303) Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, The PARAMMUNE Trial, led by Dr. Saeed Anwaar Saeed UPMC Hillman Cancer Center SWOG Cancer Research Network Learn more: buff.ly/3UQl6U4

In JNCI: % change in tumor measure per RECISTv1.1 had linear assoc w PFS & OS in patients w rare cancers who had combo ICI in SWOG Cancer Research Network S1609 #DART . Lee Ellis
Correlation between tumor size change & outcome in a rare cancer immunotherapy basket trial academic.oup.com/jnci/article-a…

Congrats Laura Esfeller on your 8 year #cancerversary !!! Each year is so very precious & worth celebrating!! SWOG Cancer Research Network #patientadvocate The Hope Foundation for Cancer Research

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

Drivers of Clinical Trial Participation -- Demographics, Disparities, and Eligibility Criteria [Jan 10, 2019] Mishkin, Arnaldez, Ivy JAMA Oncology ow.ly/okeU30o3vAc #ClinicalTrials SWOG Cancer Research Network #SWOGonc

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation [Jan 10, 2019] DrJoeUnger et al. JAMA Oncology ow.ly/Atg730o3v1F #ClinicalTrials SWOG Cancer Research Network #SWOGonc

Our #TranslationalMedicine link of the week, chosen by SWOG Cancer Research Network's Lee Ellis & Jimmy Rae, PhD:
Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions
doi.org/10.1158/2159-8…

Congrats Hedyeh Ebrahimi & mentors @arafflemed Sumanta K. Pal, MD, FASCO 👉important data on challenges faced by community cancer centers to engage in clinical trials in JAMA Network Open 👉 support is needed from pharmaceutical companies , health care policymakers, etc OncoAlert ASCO SWOG Cancer Research Network